Physician profile
Patrick M Ambrosio
NPI 1295765675
$5,907.00
in general payments reported to CMS, 2019-2025
38 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $974 · 2020: $718 · 2021: $611 · 2022: $633 · 2023: $772 · 2024: $726 · 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,795 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,794.92 |
| Education | $176.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,061.24 | 2019-2025 | |
| Glaxosmithkline, LLC. | $732.83 | 2019-2025 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $564.71 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $546.43 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Csl Behring | $415.99 | 2019-2025 | Hizentra, Haegarda, Andembry |
| Optinose US, INC. | $402.83 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $235.73 | 2022-2025 | |
| Kaleo, INC. | $176.87 | 2019-2024 | Auvi-Q |
| Grifols USA, LLC | $171.85 | 2019-2025 | Xembify |
| Amgen INC. | $157.45 | 2022-2025 | Tezspire |
| Alk-Abello, INC | $155.32 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.64 | 2020-2025 | Cuvitru, Eohilia |
| Pfizer INC. | $149.93 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $98.48 | 2020-2022 | |
| Octapharma USA, INC. | $94.25 | 2019-2023 | Panzyga |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Ambrosio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.